Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 35, 2003 - Issue 6-7
Submit an article Journal homepage
44
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Influenza Vaccine Coverage and Reasons for Non-vaccination in a Sample of People Above 65 Years of Age, in Sweden, 1998-2000

Eva Dannetun Department of Epidemiology Swedish Institute for Infectious Disease Control Solna
,
Anders Tegnell Department of Epidemiology Swedish Institute for Infectious Disease Control Solna
,
Bengt Normann Department of Communicable Disease Control Landstinget i ÖstergÖtland LinkÖping
,
Örjan Garpenholt Örebro County Council Department of Health Örebro
&
Johan Giesecke Department of Epidemiology Swedish Institute for Infectious Disease Control Solna
Pages 389-393 | Published online: 08 Jul 2009

References

  • Bovier PA, Chamot E, Bouvier Gallacchi M, Loutan L. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 2001; 19: 4760–7.
  • Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84.
  • Marshall MacBean A, Babish JD, Warren L. The impact and cost of influenza in elderly. Arch Intern Med 1993; 153: 2105–11.
  • Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A metaanalysis and review of the literature. Ann Intern Med 1995; 123: 518–27.
  • Nicholson KG. Managing influenza in primary care. London: Blackwell Science; 1999.
  • Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944–50.
  • Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769–76.
  • Christenson B, Lundbergh P, Hedlund J, Örtqvist Å. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357: 1008–11.
  • Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC. Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence. Drugs Aging 2000; 17: 217–27.
  • Gosney M. Factors affecting influenza vaccination rates in older people admitted to hospital with acute medical problems. J Adv Nurs 2000; 32: 892–7.
  • Pregliasco F, Sodano L, Mensi C, Selvaggi MT, Adamo B, Argenio PD, et al. Influenza vaccination among the elderly in Italy. Bull World Health Organ 1999; 77: 127–31.
  • Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults. Ann Intern Med 1988; 108: 616–25.
  • Hak E, Hermens R, Hoes A, Verheij T, Kuyvenhoven M, van Essen A. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scand J Prim Health Care 2000; 18: 237–41.
  • Luthi JC, Mean F, Ammon C, Burnand B. Evaluation of a population-based prevention program against influenza among Swiss elderly people. Swiss Med Wkly 2002; 132: 592–7.
  • Danish Institute for Health Technology Assessment. Influenza vaccination of the elderly. Copenhagen: DIHTA; 2000. 2 (1). (In Danish.)
  • Höglund D, Stenqvist K. Influenza vaccination coverage among the elderly in the Göteborg area. Lakartidningen 2001; 98: 156–8.
  • Österlund A. Det är hög tid att vi rekommenderar landstingen att ge riskgrupperna gratis influensavaccin (High time to recommend the County Councils to give free influenza vaccine to risk groups). Smittskydd 2001; 4: 45–6.
  • Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999; 16: 173–7.
  • Ganguly R, Webster TB. Influenza vaccination in the elderly. J Invest Allerg Clin Immun 1995; 5: 73–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.